SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.08-2.9%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (14714)12/26/2004 4:04:47 AM
From: Henry Niman  Read Replies (2) of 52153
 
Richard, Since you haven't come up with an opinion on the WSN/33 sequences in swine in Korea (other than nonsense about contamination), and this is where the SI Biotech "gurus" hang out, here are a few additional data points that you can factor in.

The WSN/33 swine sequences are over 99% homologous to WSN/33 in all 8 genes (only half of PB2 is present, but that half is over 99% homologous to WSN/33). However, there are a few polymorphisms that are in all of the WSN/33 swine sequences, but not in WSN/33 or avian sequences. Instead, these polymorphisms are found in various swine isolates with human like surface proteins (subtypes H1N1, H1N2, H2N2, H3N2), including many in the midwest. The swine isolates are now showing up in turkeys in Minnesota, North Carolina, and Ohio.

recombinomics.com

Thus, your contamination allusions not only need to get contaminating WSN/33 sequences into the pigs in Korea, but also explain the more modern polymorphisms which are showing up this year and last year in the US turkeys (as well as midwestern US swine from the past several years).

I expect this story to break next week, and it will NOT be good news for Biotechs, because the public doesn't like lethal lab escapees.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext